DE60022193D1 - Screeningverfahren für verbindungen welche die melanogenese beeinflussen - Google Patents

Screeningverfahren für verbindungen welche die melanogenese beeinflussen

Info

Publication number
DE60022193D1
DE60022193D1 DE60022193T DE60022193T DE60022193D1 DE 60022193 D1 DE60022193 D1 DE 60022193D1 DE 60022193 T DE60022193 T DE 60022193T DE 60022193 T DE60022193 T DE 60022193T DE 60022193 D1 DE60022193 D1 DE 60022193D1
Authority
DE
Germany
Prior art keywords
compounds
melange
influence
environment
screening method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60022193T
Other languages
English (en)
Other versions
DE60022193T2 (de
Inventor
J Orlow
Prashiela Manga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22496233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60022193(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New York University NYU filed Critical New York University NYU
Application granted granted Critical
Publication of DE60022193D1 publication Critical patent/DE60022193D1/de
Publication of DE60022193T2 publication Critical patent/DE60022193T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/207—Pigmentation disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60022193T 1999-06-29 2000-06-27 Screeningverfahren für verbindungen welche die melanogenese beeinflussen Expired - Fee Related DE60022193T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14156399P 1999-06-29 1999-06-29
US141563P 1999-06-29
PCT/IB2000/000861 WO2001001131A1 (en) 1999-06-29 2000-06-27 Screening methods for compounds that affect melanogenesis

Publications (2)

Publication Number Publication Date
DE60022193D1 true DE60022193D1 (de) 2005-09-29
DE60022193T2 DE60022193T2 (de) 2006-06-08

Family

ID=22496233

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60022193T Expired - Fee Related DE60022193T2 (de) 1999-06-29 2000-06-27 Screeningverfahren für verbindungen welche die melanogenese beeinflussen

Country Status (12)

Country Link
EP (1) EP1190248B1 (de)
JP (1) JP2003503705A (de)
KR (1) KR100823383B1 (de)
AT (1) ATE302948T1 (de)
AU (1) AU774007B2 (de)
CA (1) CA2377163A1 (de)
DE (1) DE60022193T2 (de)
HU (1) HUP0201647A3 (de)
IL (2) IL146228A0 (de)
TW (2) TW200716979A (de)
WO (1) WO2001001131A1 (de)
ZA (1) ZA200109205B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
WO2003095645A1 (en) * 2002-05-09 2003-11-20 New York University Assay for melanogenesis
DE102004007032A1 (de) * 2004-02-12 2005-08-25 Beiersdorf Ag Antisense-Oligonukleotide zur Behandlung von unerwünschter Pigmentierung der Haut und der Haare
JP4819727B2 (ja) * 2007-03-19 2011-11-24 株式会社コーセー 美白成分のスクリーニング方法
WO2009064493A1 (en) * 2007-11-14 2009-05-22 New York University School Of Medicine Tricyclic compounds as melanogenesis modifiers and uses thereof
WO2011094016A1 (en) 2010-01-28 2011-08-04 New York University Compounds, compositions and methods for preventing skin darkening
US8772252B2 (en) 2011-01-27 2014-07-08 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
JP5563710B2 (ja) * 2013-11-05 2014-07-30 株式会社ファンケル 皮膚色素沈着マーカーとその利用技術
JPWO2019098352A1 (ja) * 2017-11-17 2021-01-14 ロート製薬株式会社 美容組成物、スクリーニング方法及び美容方法
EP3785696A1 (de) 2019-08-28 2021-03-03 B.R.A.I.N. Biotechnology Research And Information Network AG Kosmetische verwendung von aromatische formamidinderivate
BR112023023386A2 (pt) * 2021-05-10 2024-01-23 Nikhil Goel Células engenheiradas para produção aumentada de proteínas de difícil expressão

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292291B1 (de) * 1987-05-22 1994-08-10 University Patents, Inc. Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung
JPH04505249A (ja) * 1989-04-26 1992-09-17 スローン―ケツテリング・インステイテユート・フオー・キヤンサー・リサーチ 生物学的に活性なヒトチロシナーゼを構成的に発現する非メラノサイト真核細胞及びその使用
US5540914A (en) * 1989-12-15 1996-07-30 The Board Of Regents Of The University Of Oklahoma Pigmentation enhancer and method
JPH0648935A (ja) * 1992-06-02 1994-02-22 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
JP3532945B2 (ja) * 1993-11-16 2004-05-31 ポーラ化成工業株式会社 抗ヒトチロシナーゼモノクローナル抗体
JPH07324095A (ja) * 1994-05-30 1995-12-12 Hideji Itokawa 環状ペプチドシュードステラリン並びにこれを含有するチロシナーゼ活性阻害剤、メラニン生成抑制剤および皮膚化粧料

Also Published As

Publication number Publication date
ZA200109205B (en) 2003-04-30
IL146228A (en) 2007-07-24
KR20020042541A (ko) 2002-06-05
WO2001001131A1 (en) 2001-01-04
HUP0201647A2 (en) 2002-08-28
AU5241900A (en) 2001-01-31
JP2003503705A (ja) 2003-01-28
DE60022193T2 (de) 2006-06-08
ATE302948T1 (de) 2005-09-15
TW200718944A (en) 2007-05-16
TW200716979A (en) 2007-05-01
IL146228A0 (en) 2002-07-25
EP1190248A1 (de) 2002-03-27
KR100823383B1 (ko) 2008-04-17
CA2377163A1 (en) 2001-01-04
AU774007B2 (en) 2004-06-10
EP1190248B1 (de) 2005-08-24
HUP0201647A3 (en) 2011-01-28

Similar Documents

Publication Publication Date Title
ES2157684T3 (es) Composicion de blanqueo de la piel y/o de los cabellos.
HUP0101149A2 (hu) Illatfokozó készítmények kozmetikai termékekhez
TR200401638T2 (tr) Bir reseptöre bağlanan peptidler ve bileşikler.
BR0011838B1 (pt) elemento de sela e estrutura de misturador estático.
CY1110128T1 (el) Καταλυτικα μονοκλωνικα αντισωματα με δραστικοτητα πρωτεασης για την εκλεκτικη λυση του πρωτεϊνικου συστατικου των πλακων και συνονθυλευματων που σχετιζονται με παθολογικες καταστασεις
DE60022193D1 (de) Screeningverfahren für verbindungen welche die melanogenese beeinflussen
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
MXPA02002118A (es) Composiciones que contienen productos leguminosos.
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
WO2002098347A3 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
DE60039622D1 (de) Verwendung von Fucoidin als haarwuchsfördernder Bestandteil
MXPA02002119A (es) Productos leguminosos.
ID27020A (id) Metoda kosmetik perwatan kulit
AR024846A1 (es) Composiciones cosmeticas para el cuidado de la piel que contienen 4-cromanona.
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE69903137D1 (de) Oleamid-glycyl-glycine derivate für die kosmetik und/oder dermatologie
DE60044633D1 (de) Nicht therapeutische Verwendung von N-acetylglucosamin zur Hautschälung
ATE295175T1 (de) Verwendung von unverseifbaren pflanzlichen ölen für die herstellung pharmazeutischer präparate
IT1302023B1 (it) Composizione cosmetica deodorante e/o idratante.
MXPA99011362A (es) Empleo de 2-mercapto-piridin-n-oxido.
WO1997000892A3 (en) Depigmenting activity of agouti signal protein and peptides thereof
DE60235132D1 (de) Sojaprodukte enthaltende Zusammensetzungen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee